As shown in Fig. 3, dose-dependent inhibition of CDK11p110 mRNA and protein expression were observed, which demonstrates that the suppressed cell viability was associated with the knockdown of CDK11p110 in breast cancer cells. Here, CDK11A is linked to breast cancer.